7.66
-1.59 (-17.19%)
| Penutupan Terdahulu | 9.25 |
| Buka | 7.75 |
| Jumlah Dagangan | 300 |
| Purata Dagangan (3B) | 1,068 |
| Modal Pasaran | 29,786,638 |
| Harga / Jualan (P/S) | 165.98 |
| Harga / Buku (P/B) | 21.13 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Aug 2025 - 18 Aug 2025 |
| Margin Operasi (TTM) | -13,411.40% |
| EPS Cair (TTM) | -4.88 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 662.70% |
| Nisbah Semasa (MRQ) | 0.390 |
| Aliran Tunai Operasi (OCF TTM) | -4.04 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.04 M |
| Pulangan Atas Aset (ROA TTM) | -948.38% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Zivo Bioscience, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -2.5 |
| Purata | 0.88 |
|
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 64.12% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Corecap Advisors, Llc | 31 Dec 2025 | 4,360 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |